Filing metadata

Accession number
0000950170-25-023632
Form type
Form 4
Filer
BridgeBio Pharma, Inc.
CIK
CIK 1743881
Filed
Feb 19, 2025
Reporting period
Feb 16, 2025
Description
Insider transaction

Explore SEC Filings Hub